Menu

Home / For Visitors / 2025 Exhibitor Product / Belloxa (Oxaliplatin)

Belloxa (Oxaliplatin)

Model: Liquid Injection (in vial)

Category: Pharmaceutical

Exhibitor: CKD OTTO PHARMACEUTICALS

Booth No: M625

Characteristic

Strength : 50 mg & 100 mg
Dosage form : Liquid Injection
Indication: Colorectal cancer

Oxaliplatin in combination with 5-Fluorouracil (5-FU) and folinic acid (FA) is indicated for:
adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumor
treatment of metastatic colorectal cancer

Storage Condition :
Store below 30°C, in a hermetic container.
Solutions of reconstituted Oxaliplatin should be used no more than 24 hours after reconstitution and stored at 2-8°C. Store the vial in the outer packaging, protected from light. Do not freeze.

Other Products

Products you may be interested in

Highest Rated Products

TOP